The publisher's Medical Devices sector report, “Specific Proteins Tests - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Specific Proteins Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Specific Proteins Tests are reagents and test kits which are used to quantify and detect protein molecules from bodily fluids. immunoglobulins (without IgE), HAMA, Immunoelectrophoresis & immunofixation kits, complement components, transport proteins, lipoproteins, AGP, AAT, micro and macro G etc. have been tracked under this segment.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Specific Proteins Tests are reagents and test kits which are used to quantify and detect protein molecules from bodily fluids. immunoglobulins (without IgE), HAMA, Immunoelectrophoresis & immunofixation kits, complement components, transport proteins, lipoproteins, AGP, AAT, micro and macro G etc. have been tracked under this segment.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Specific Proteins Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Specific Proteins Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Specific Proteins Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Specific Proteins Tests - Pipeline Products under Development by Companies
5 Specific Proteins Companies and Product Overview
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Diagnostics
- Alfa Wassermann Diagnostic Technologies, LLC
- Amerimmune LLC
- Beckman Coulter Inc
- China Medical Technologies Inc (Inactive)
- Colorado State University
- Fujirebio Diagnostics Inc
- Genesis Detection Systems, Inc.
- Genome Diagnostics Pvt Ltd
- Guanine Inc
- Hologic Inc
- Isoformix Inc
- Ortho Clinical Diagnostics Holdings Plc
- Ottawa Hospital Research Institute
- Roche Diagnostics International Ltd
- Sebia SA
- Siemens Healthcare Diagnostics Inc
- SomaLogic Inc
- Umea University
- University of California
